yingweiwo

NF-κB

NF-κB

Nuclear factor-κB (NF-κB)/Rel proteins include NF-κB2 p52/p100, NF-κB1 p50/p105, c-Rel, RelA/p65, and RelB.These proteins perform as two-component transcription factors that control gene expression and have an impact on a variety of biological processes, such as innate and acquired immunity, inflammation, stress responses, B-cell development, and lymphoid organogenesis.The immune system's reaction to infection is significantly regulated by NF-B. In addition, the etiology of chronic inflammatory illnesses such inflammatory bowel disease, rheumatoid arthritis, and asthma is influenced by the activation of the NF-B pathway. Septic shock, autoimmune and inflammatory disorders, viral infections, and poor immunological development have all been connected to faulty NF-B regulation.

NF-κB related products

Structure Cat No. Product Name CAS No. Product Description
Beauveriolide I V82269 Beauveriolide I 154491-55-1 Beauveriolide I is a metabolite of the entomopathogenic fungus Beauveria sp.
biKEAP1 V84593 biKEAP1
Bisphenol A-d16 (bisphenol A-d16) V82274 Bisphenol A-d16 (bisphenol A-d16) 96210-87-6 Bisphenol A-d16 is the deuterium labelled form of Bisphenol A.
Bisphenol A-d4-1 (bisphenol A-d4-1) V82273 Bisphenol A-d4-1 (bisphenol A-d4-1) 347841-41-2 Bisphenol A-d4-1 is the deuterated form of Bisphenol A.
Bisphenol A-d6 (bisphenol A d6) V82272 Bisphenol A-d6 (bisphenol A d6) 86588-58-1 Bisphenol A-d6 is the deuterium labelled form of Bisphenol A.
Bisphenol A-d8 (bisphenol A-d8) V82276 Bisphenol A-d8 (bisphenol A-d8) 92739-58-7 Bisphenol A-d8 is a phenolic organic synthetic compound extensively used in the production of polycarbonate plastics and epoxy resins.
BPD V107829 BPD 213481-12-0 BPD is a COX-2 and TAK1-NF-κB inhibitor with IC50 of 18.5 μM for COX-2.
C25-140 V17405 C25-140 1358099-18-9 C25-140 (C-25140;C25140) is a novel, first-in-class and potent inhibitor of RING-E3 ligase (TRAF6) / E2 enzyme (Ubc13) protein-protein interaction (PPI) with potential use forautoimmune and chronic inflammatory diseases.
cAIMP V103069 cAIMP 1507367-51-2 cAIMP (cyclic adenosine-inosine monophosphate) is a potent synthetic cyclic dinucleotide.
Cannabidiorcol (O-1821; CBD-C1) V82254 Cannabidiorcol (O-1821; CBD-C1) 35482-50-9 Cannabidiorcol (CBDO, CBD-C1, O-1821) an analogue of cannabidiol with its pentyl side chain shortened to a methyl group.
CAY10512 V83482 CAY10512 139141-12-1
CAY10657 V101720 CAY10657 494772-86-0 CAY10657 is an inhibitor of the NF-κB pathway that can downregulate the expression of proinflammatory cytokines (IL-6) and chemokines (MCP-1), thereby exerting an anti-inflammatory effect on Streptococcus suis-induced meningitis.
CBL0137 V3172 CBL0137 1197996-80-7 CBL0137 (formerly known as Curaxin 137 or CBL-0137) is an inhibitor of the histone chaperone,FACT (facilitates chromatin transcription complex).
CD40-TRAF6 inhibitor V17766 CD40-TRAF6 inhibitor 433249-94-6 CD40-TRAF6 inhibitor (TRAF-STOP inhibitor 6877002) is a novel and potent inhibitor of CD40-TRAF6 protein protein interaction with the potential for treatingatherosclerosis.
Chebulanin V84712 Chebulanin 166833-80-3
cis-Vitamin K1 (cis-Phylloquinone; cis-Phytomenadione) V82284 cis-Vitamin K1 (cis-Phylloquinone; cis-Phytomenadione) 16033-41-3 Cis-Vitamin K1 is an endogenously produced metabolite of Vitamin K.
CORM-3 V1935 CORM-3 475473-26-8 CORM-3 is a water-soluble carbon monoxide (CO)-releasing molecule with potent anti-inflammatory and cardioprotective activity byattenuatingNF-κB p65 nuclear translocation, reducing ROS generation and enhancing intracellular glutathione and superoxide dismutase levels.
COX-2-IN-51 V105157 COX-2-IN-51 3064260-49-4 COX-2-IN-51 (E25) is a potent COX-2 inhibitor with IC50 of 70.7 nM.
COX-2/15-LOX-IN-5 V87575 COX-2/15-LOX-IN-5 443790-30-5 COX-2/15-LOX-IN-5 (Compound 4f) is a dual COX-2/15-LOX inhibitor.
Cryptanoside A V70207 Cryptanoside A 98570-81-1 Cryptanoside A is a cardiac glycoside epoxide that can be extracted from the stems of Cryptolepis dubia.
Contact Us